Cystic Fibrosis Treatments

Status

Closed
Closed Funds

This fund is temporarily closed to new patients due to lack of sufficient funding. Please continue to visit our Disease Funds page often, as replenished funds reopen as quickly as possible. If you currently have a grant with HealthWell, your grant will remain active for the entire 12 month grant cycle or until you have exhausted your allocated grant amount, whichever comes first. You can continue to use your pharmacy card or submit requests for reimbursements during your designated grant cycle.

Fund Type

Copay
Premium (Medicare Part B only)

Maximum Award Level

$15,000

Pharmacy Card Fund

Yes

Minimum Copay
Reimbursement Amount

Minimum Copay Reimbursement Amount

We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.

None

Minimum Premium
Reimbursement Amount

Minimum Premium Reimbursement Amount

We encourage you to please submit monthly reimbursement claims (even if your premium is paid on a bi-weekly basis).

None

Household Income Limit

500% of the Federal Poverty Level
(adjusted for household size and high
cost of living areas)

Fund Alerts

Sign up for email or text/call alerts to receive instant notifications.

Treatments Covered

  • Accuneb
  • Acetylcysteine Sol
  • Actigall
  • Aerochamber Plus Flowvu Chamber
  • Albuterol Hfa
  • Albuterol Inhalation Sol
  • Altera Nebulizer System
  • Arikayce
  • Atrovent (hfa)
  • Avycaz
  • Azasite
  • Azithromycin
  • Bethkis
  • Bronchitol
  • Cayston
  • Cipro
  • Ciprofloaxin
  • Colistimethate Sodium
  • Colistin
  • Coly-mycin M
  • Combivent
  • Creon
  • Devilbiss Pediatric Aerosol Mask
  • Duoneb
  • Durable Sidestream Handset
  • Fortaz
  • Handsets
  • Hudson Rci Baby Disposable Mask
  • Hudson Rci Micro Mist Handset
  • Hudson T Up-draft Ii Handset
  • Hypersal 3-7-10% W/ Pari Neb
  • Hypersal(3-7-10% Hts)
  • Hypertonic Saline Solution (3-7-10% Hts)
  • Ipratropium Combine With Albuterol
  • Kalydeco
  • Kitabis
  • Levalbuterol
  • Meropenem
  • Merrem Iv
  • Mucomyst
  • Nebcin
  • Nebusal
  • Orkambi
  • Pancreaze
  • Pari Adult Aerosol Mask
  • Pari Baby Handset
  • Pari Erapid Handset
  • Pari Lc Plus Handset
  • Pari Lc Sidestream Handset
  • Pari Lc Star Handset
  • Pari Pep S (handset Only)
  • Pari Smart Mask Kids
  • Pari Sprint Handset
  • Pari Trek S (handset Only)
  • Pari Vios Handsets
  • Pertzye
  • Philips Innospire Go (mouthpiece Only)
  • Proair Hfa
  • Proair Respiclick
  • Proventil
  • Proventil Hfa
  • Pulmosal
  • Pulmozyme
  • Respirgard Ii Nebulizer Handset
  • Respironics Side Stream Enhanced Neb Handset
  • Sodium Chloride
  • Symdeko
  • Tezacaftor/ivacaftor
  • Tobi
  • Tobi Podhaler
  • Tobramycin
  • Tobramycin Inhalation Solution
  • Trikafta
  • Ultresa
  • Ursodiol
  • Vancocin
  • Vancomycin
  • Ventolin
  • Ventolin Hfa
  • Viokace
  • Vospire Er
  • Xopenex
  • Xopenex Hfa
  • Zenpep
  • Zithromax
  • Zmax

Fund Definition

Assistance with the prescription drugs and biologics indicated for the treatment of cystic fibrosis.

Grant Utilization

HealthWell estimates that patients use an average of $3,135 during their 12-month grant period for this disease area.

About Our Cystic Fibrosis Treatments Fund

HealthWell’s Cystic Fibrosis Treatments Fund is designed to assist eligible people living with cystic fibrosis with cost-shares associated with CF-specific treatments. In addition, HealthWell is also able to consider assisting with the full cost of hypertonic saline solution, nebulizers paired with treatments, and certain handsets. We are committed to supporting the CF community and the established guidelines around our covered product list are meant to focus on the areas of greatest need for the majority of people living with CF. We understand there are additional areas to be addressed and, over time, it is our hope to be able to expand our coverage even further.

Please note that we are not able to assist with special requests outside of our covered product list at this time.

Do I Qualify?

HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:

  • Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.

  • To qualify for copayment assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. Please note that in order to qualify for premium assistance through this fund, you must have Medicare Part B. The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.

  • HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
  • If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.

 

About Cystic Fibrosis

Cystic fibrosis (CF) is a life-threatening, genetic disease that causes persistent lung infections and progressively limits the ability to breathe. In people with CF, a defective gene causes a thick, buildup of mucus in the lungs, pancreas and other organs. In the lungs, the mucus clogs the airways and traps bacteria leading to infections, extensive lung damage and eventually, respiratory failure. In the pancreas, the mucus prevents the release of digestive enzymes that allow the body to break down food and absorb vital nutrients. Source: Cystic Fibrosis Foundation

 

Additional Educational Resources

You may also visit our Resource List to view other copayment organizations that may provide assistance.